- Home
- AGO vs TVTX Comparison
AGO vs TVTX Comparison
Compare AGO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGO | TVTX |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.3B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGO | TVTX |
|---|---|---|
| Price | $85.62 | $32.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $101.00 | $37.21 |
| AVG Volume (30 Days) | 285.8K | ★ 3.1M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.00 | N/A |
| Revenue | ★ $911,000,000.00 | $435,826,000.00 |
| Revenue This Year | $4.22 | $121.59 |
| Revenue Next Year | N/A | $36.58 |
| P/E Ratio | $10.71 | ★ N/A |
| Revenue Growth | 5.08 | ★ 114.22 |
| 52 Week Low | $74.09 | $12.91 |
| 52 Week High | $94.22 | $42.13 |
Technical Indicators
Market Signals| Indicator | AGO | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 52.03 |
| Support Level | $84.52 | $29.20 |
| Resistance Level | $85.29 | $33.14 |
| Average True Range (ATR) | 1.33 | 1.46 |
| MACD | 0.14 | 0.44 |
| Stochastic Oscillator | 65.57 | 93.08 |
Price Performance
Historical ComparisonAbout AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.